TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19685729

Group type: EXPERIMENTAL
Intervention: Combined treatment of scalp-acupuncture, body-acupuncture, and abdominal-acupuncture
Number of subjects: 222

Group type: COMPARATOR
Intervention: Body-acupuncture only (control group)
Number of subjects: 222
Study: 17616785

Group type: EXPERIMENTAL
Intervention: Low-choline diet for up to 42 days or until organ dysfunction developed
Number of subjects: 33

Group type: COMPARATOR
Intervention: Baseline diet containing the recommended adequate intake of choline
Number of subjects: 33
Study: 15337874

Group type: EXPERIMENTAL
Intervention: Aspirin (150 mg daily)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Heparin administration
Number of subjects: 41
Study: 11435050

Group type: EXPERIMENTAL
Intervention: Tracheal intubation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA) insertion
Number of subjects: 40
Study: 31262398

Group type: EXPERIMENTAL
Intervention: Trazodone sustained-release tablets (TSR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trazodone immediate-release formulation (TIR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Food conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple dosage of TSR and TIR
Number of subjects: 0
Study: 7797125

Group type: EXPERIMENTAL
Intervention: Octreotide (50 micrograms, subcutaneously, three times daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2152036

Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA) with propofol (group P)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Balanced‐anaesthesia with sodium thiopental + isoflurane + N2O (group M)
Number of subjects: 40
Study: 383719

Group type: EXPERIMENTAL
Intervention: AO‐plate fixation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conservative methods
Number of subjects: 100
Study: 31671801

Group type: EXPERIMENTAL
Intervention: Grey Wolf Optimization (GWO) with Multi-Layer Perceptron (MLP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biogeography-Based Optimization (BBO) with Multi-Layer Perceptron (MLP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BBO-based ensemble
Number of subjects: 0
Study: 28251726

Group type: EXPERIMENTAL
Intervention: CSII
Number of subjects: 24

Group type: COMPARATOR
Intervention: MDI
Number of subjects: 24
Study: 25814050

Group type: EXPERIMENTAL
Intervention: Solifenacin succinate 5-10 mg daily
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Solifenacin succinate (open label phase)
Number of subjects: 23
Study: 22823583

Group type: EXPERIMENTAL
Intervention: Bilateral electroacupuncture at Sanyinjiao (SP6) for Cold and Dampness Stagnation pattern
Number of subjects: 501

Group type: COMPARATOR
Intervention: Bilateral electroacupuncture at Xuanzhong (GB39) for Cold and Dampness Stagnation pattern
Number of subjects: 501

Group type: COMPARATOR
Intervention: Bilateral electroacupuncture at nonacupoint for Cold and Dampness Stagnation pattern
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Bilateral electroacupuncture at Sanyinjiao (SP6) for Qi and Blood Stagnation pattern
Number of subjects: 501

Group type: COMPARATOR
Intervention: Bilateral electroacupuncture at Xuanzhong (GB39) for Qi and Blood Stagnation pattern
Number of subjects: 501

Group type: COMPARATOR
Intervention: Bilateral electroacupuncture at nonacupoint for Qi and Blood Stagnation pattern
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Bilateral electroacupuncture at Sanyinjiao (SP6) for Qi and Blood Deficiency pattern
Number of subjects: 501

Group type: COMPARATOR
Intervention: Bilateral electroacupuncture at Xuanzhong (GB39) for Qi and Blood Deficiency pattern
Number of subjects: 501

Group type: COMPARATOR
Intervention: Bilateral electroacupuncture at nonacupoint for Qi and Blood Deficiency pattern
Number of subjects: 501
Study: 21097688

Group type: EXPERIMENTAL
Intervention: Revalor‐X (200 mg of TBA and 40 mg of E(2))
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Revalor‐IS/S (200 mg of TBA and 40 mg of E(2); reimplanted at 68 to 74 d)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Revalor‐S (120 mg of TBA and 24 mg of E(2))
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Revalor‐IS/S (reimplanted at 44 to 47 d)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Revalor‐X
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Revalor‐IS/S (reimplanted at 90 to 103 d)
Number of subjects: 10
Study: 19863709

Group type: EXPERIMENTAL
Intervention: Interactive lecture
Number of subjects: 157

Group type: COMPARATOR
Intervention: Computerised tutorial
Number of subjects: 157
Study: 17443749

Group type: COMPARATOR
Intervention: Hydrotherapy classes
Number of subjects: 152

Group type: COMPARATOR
Intervention: Tai Chi classes
Number of subjects: 152
Study: 15291654

Group type: EXPERIMENTAL
Intervention: Active rTMS (high frequency over left DLPFC)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Active rTMS (combined high- and low-frequency to left and right DLPFC)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 41
Study: 11440285

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/d
Number of subjects: 240

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/d
Number of subjects: 240
Study: 9931911

Group type: EXPERIMENTAL
Intervention: HAI 5-FU/FA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HAI FUDR
Number of subjects: 0

Group type: COMPARATOR
Intervention: i.v. 5-FU/FA
Number of subjects: 0
Study: 9848303

Group type: EXPERIMENTAL
Intervention: Autologous endometrial coculture
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional medium
Number of subjects: 42
Study: 2784007

Group type: EXPERIMENTAL
Intervention: Stimulation of locus coeruleus (LC) with chronic unilateral electrodes; stimulation involved a 6-min stimulus with discontinuous bursts of pulses.
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Stimulation of locus coeruleus (LC) for epilepsy management.
Number of subjects: 3
Study: 334472

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (300 mg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Aspirin (2.1 g/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Phenylbutazone (600 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 28820857

Group type: EXPERIMENTAL
Intervention: DJ40
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: DJ40 and DJ60
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 60-second jump test
Number of subjects: 11
Study: 29199544

Group type: EXPERIMENTAL
Intervention: Telehealth-based weight loss program with video conference health coaching support
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no active intervention)
Number of subjects: 25
Study: 28608601

Group type: COMPARATOR
Intervention: Sham acupuncture treatment for 8 weeks
Number of subjects: 196
Study: 25859828

Group type: EXPERIMENTAL
Intervention: Transvaginal sonography (5‐9 MHz) for detecting anal sphincter injuries
Number of subjects: 201
Study: 23727631

Group type: EXPERIMENTAL
Intervention: Tart cherry juice
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 21663885

Group type: EXPERIMENTAL
Intervention: Care guided by hand‐carried echocardiography
Number of subjects: 453

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Care guided by hand‐carried echocardiography (subgroup analysis)
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Hand‐carried echocardiography
Number of subjects: 453
Study: 19638111

Group type: EXPERIMENTAL
Intervention: GlideScope laryngoscope
Number of subjects: 60

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both GlideScope and Macintosh laryngoscopes
Number of subjects: 60
Study: 16682420

Group type: EXPERIMENTAL
Intervention: HIV prevention course promoting condom use
Number of subjects: 10954

Group type: EXPERIMENTAL
Intervention: HIV prevention course promoting condom use with emergency contraception
Number of subjects: 10954

Group type: COMPARATOR
Intervention: Existing sex education course
Number of subjects: 10954
Study: 14699368

Group type: EXPERIMENTAL
Intervention: Localized high-dose UVA1 irradiation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Topical cream psoralen-UVA (PUVA)
Number of subjects: 27
Study: 11726262

Group type: EXPERIMENTAL
Intervention: HMB (3g.day(‐1))
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Leucine (LEU, 3g.day(‐1))
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (CON, 3g.day(‐1))
Number of subjects: 8
Study: 9163613

Group type: EXPERIMENTAL
Intervention: Aspirin (40 mg/d)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 8203796

Group type: EXPERIMENTAL
Intervention: Flunisolide nasal spray
Number of subjects: 100

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate nasal spray
Number of subjects: 100
Study: 3280157

Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g bid, orally)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: L-carnitine (3 g as a bolus followed by an infusion of 2 mg/kg/min for 30 min, intravenously)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30772754

Group type: EXPERIMENTAL
Intervention: Intravenous Immunoglobulin (IVIG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (albumin)
Number of subjects: 39
Study: 27702556

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (IH) plus body weight‐supported treadmill training (BWSTT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Continued normoxia (placebo) plus body weight‐supported treadmill training (BWSTT)
Number of subjects: 35
Study: 25262459

Group type: EXPERIMENTAL
Intervention: Mediterranean lifestyle intervention (educational program on nutrition and monitored physical activity)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Conventional follow-up (control group)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Mediterranean lifestyle intervention
Number of subjects: 260
Study: 23808255

Group type: EXPERIMENTAL
Intervention: Glutamine solution intravenous use
Number of subjects: 40

Group type: COMPARATOR
Intervention: Parenteral feeding
Number of subjects: 40
Study: 21680040

Group type: EXPERIMENTAL
Intervention: Diabetes-specific formula (DSF) - Diasip(®) 2×200mL/day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard, fiber-containing formula
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Diabetes-specific formula (DSF) - Diasip(®)
Number of subjects: 44
Study: 18665366

Group type: EXPERIMENTAL
Intervention: MSCT‐AG
Number of subjects: 15

Group type: COMPARATOR
Intervention: MR‐AG
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: MSCT‐AG and MR‐AG
Number of subjects: 15
Study: 17044400

Group type: EXPERIMENTAL
Intervention: Fuzzy discrete event system regimen selection
Number of subjects: 35
Study: 15242140

Group type: EXPERIMENTAL
Intervention: HSCL-D-13
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: HSCL-D-20
Number of subjects: 656
Study: 11010932

Group type: EXPERIMENTAL
Intervention: Higher fruit and vegetable intake (quintiles: 2.6, 4.1, 5.5, 7.1, and 10.2 servings/day)
Number of subjects: 39876

Group type: EXPERIMENTAL
Intervention: Higher fruit and vegetable intake (after excluding participants with diabetes, hypertension, or high cholesterol)
Number of subjects: 39876

Group type: EXPERIMENTAL
Intervention: Higher fruit and vegetable intake
Number of subjects: 39876
Study: 9162510

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extended field radiotherapy
Number of subjects: 0
Study: 8378158

Group type: EXPERIMENTAL
Intervention: Sorbitol gum chewing initiated after 5 min
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sorbitol gum chewing initiated after 15 min
Number of subjects: 5
Study: 3517890

Group type: EXPERIMENTAL
Intervention: 200 mg pyritinol three times daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 29102514

Group type: EXPERIMENTAL
Intervention: omalizumab 300 mg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: omalizumab 150 mg
Number of subjects: 105

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 105
Study: 26505573

Group type: EXPERIMENTAL
Intervention: Cortical Input (CI)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Composite Variability Index (CVI)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: BIS and CCS
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CI and CCS
Number of subjects: 80
Study: 25487196

Group type: EXPERIMENTAL
Intervention: Wood smoke exposure (1 mg/m³ particulate matter concentration)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Filtered air
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Wood smoke exposure
Number of subjects: 16
Study: 21838788

Group type: EXPERIMENTAL
Intervention: Adjusted dosing algorithm for HDMTX based on 24 h MTX plasma concentrations.
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard MTX dose (not explicitly detailed in the abstract).
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Adjusted dose (based on dosing algorithm).
Number of subjects: 131
Study: 19961836

Group type: EXPERIMENTAL
Intervention: Amphetamine (an indirect DA agonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haloperidol (DA D2 receptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18316153

Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise at 1%, 15%, and 25% of maximum voluntary contraction (MVC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise
Number of subjects: 24
Study: 15627855

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT-A) - 25 sessions
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT-B) - after contact control period
Number of subjects: 72

Group type: COMPARATOR
Intervention: Contact Control Group (CCG)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT-A)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT-B)
Number of subjects: 72
Study: 12798827

Group type: EXPERIMENTAL
Intervention: Revascularisation in addition to optimal medical therapy (ACE inhibitors, beta-blockers, aldosterone antagonists, anti-thrombotic agent)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Optimal medical therapy (ACE inhibitors, beta-blockers, aldosterone antagonists, anti-thrombotic agent) without revascularisation
Number of subjects: 800
Study: 10577695

Group type: EXPERIMENTAL
Intervention: 8 Gy x 1
Number of subjects: 1171

Group type: COMPARATOR
Intervention: 4 Gy x 6
Number of subjects: 1171
Study: 9127689

Group type: EXPERIMENTAL
Intervention: Invasive ductal carcinoma
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fibroadenoma
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Adjacent breast stroma of invasive ductal carcinoma
Number of subjects: 20

Group type: COMPARATOR
Intervention: Adjacent breast stroma of fibroadenoma
Number of subjects: 20
Study: 1833121

Group type: EXPERIMENTAL
Intervention: Acarbose (100 mg three times a day for 6 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (three times a day for 6 weeks)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Acarbose (first treatment)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (first treatment)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Acarbose (second treatment)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (second treatment)
Number of subjects: 14
Study: 6341844

Group type: EXPERIMENTAL
Intervention: Cimetidine (300 mg with meals and at bedtime)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Antacid (15 ml one hour after meals and at bedtime)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cimetidine and Antacid
Number of subjects: 101
Study: 30924402

Group type: EXPERIMENTAL
Intervention: CRCS information plus a photo and text narrative of a CRC survivor
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: CRCS information plus a photo and text narrative of a CRC screener who did not have cancer
Number of subjects: 477

Group type: COMPARATOR
Intervention: CRCS information only
Number of subjects: 477
Study: 29119807

Group type: EXPERIMENTAL
Intervention: Beliefs About Medication Scale (BAMS)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Intent to adhere (IA)
Number of subjects: 76
Study: 26647918

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 23609584

Group type: EXPERIMENTAL
Intervention: Dry needling therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no dry needling)
Number of subjects: 120
Study: 22077915

Group type: EXPERIMENTAL
Intervention: Calen (7 days)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Calen (14 days)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Calen/camphorated paramonochlorophenol (CMCP) (7 days)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Calen/CMCP (14 days)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Calen/0.4% chlorhexidine (CHX) (7 days)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Calen/0.4% CHX (14 days)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Calen/1% CHX (7 days)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Calen/1% CHX (14 days)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Chemo‐mechanical preparation with no medication
Number of subjects: 106

Group type: COMPARATOR
Intervention: No chemo‐mechanical preparation and no medication
Number of subjects: 106
Study: 19170903

Group type: EXPERIMENTAL
Intervention: Dedicated bipolar RV leads
Number of subjects: 292

Group type: COMPARATOR
Intervention: Integrated bipolar RV leads
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Both lead types
Number of subjects: 292
Study: 17255739

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir (LPV/r) 533 mg/133 mg twice daily + efavirenz (EFV) 600 mg once daily
Number of subjects: 236

Group type: COMPARATOR
Intervention: EFV + two nucleoside reverse transcriptase inhibitors (NRTI)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: LPV/r + EFV
Number of subjects: 236

Group type: COMPARATOR
Intervention: EFV + NRTI
Number of subjects: 236
Study: 15963081

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.d.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg t.d.s. with Omeprazole
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo-matching tegaserod t.d.s.
Number of subjects: 40
Study: 14581667

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1.5 MAC
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 2 MAC
Number of subjects: 16

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 16
Study: 10235417

Group type: EXPERIMENTAL
Intervention: 40 mg pantoprazole
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8946232

Group type: EXPERIMENTAL
Intervention: rHu‐EPO (one year)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: rHu‐EPO (two years)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 37
Study: 1958158

Group type: EXPERIMENTAL
Intervention: Brief intensive group cognitive behavioural therapy (2 days)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 97
Study: 6120011

Group type: EXPERIMENTAL
Intervention: EMG feedback
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Cognitive monitoring training
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Systematic desensitization
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: High expectancy discussion group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Waiting list controls
Number of subjects: 160
Study: 31690988

Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg once daily for 26 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo for 26 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 31187612

Group type: EXPERIMENTAL
Intervention: Caudal block with analgosedation (group CB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: General endotracheal anaesthesia (group GA)
Number of subjects: 40
Study: 29282075

Group type: EXPERIMENTAL
Intervention: OxCAP-MH
Number of subjects: 172
Study: 26350816

Group type: EXPERIMENTAL
Intervention: Coenzyme A (CoA) 400 U/d
Number of subjects: 216

Group type: COMPARATOR
Intervention: pantethine 600 U/d
Number of subjects: 216
Study: 23334063

Group type: EXPERIMENTAL
Intervention: Alternate nostril yoga breathing for 10 minutes
Number of subjects: 90

Group type: COMPARATOR
Intervention: Breath awareness for 10 minutes
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control intervention (reading a magazine)
Number of subjects: 90
Study: 21333060

Group type: EXPERIMENTAL
Intervention: AeroEclipse breath-actuated nebulizer
Number of subjects: 149

Group type: COMPARATOR
Intervention: Standard therapy (small-volume nebulizer or 1-hour continuous nebulization)
Number of subjects: 149
Study: 19244376

Group type: EXPERIMENTAL
Intervention: Bread fortified with 125 microg (5000 IU) vitamin D(3) per daily serving
Number of subjects: 45
Study: 17132479

Group type: EXPERIMENTAL
Intervention: Site-specific rectocele repair augmented with a porcine small intestinal submucosa graft
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Site-specific rectocele repair
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Posterior colporrhaphy
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: All groups (including graft augmentation, site-specific repair, and posterior colporrhaphy)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 106
Study: 12767421

Group type: EXPERIMENTAL
Intervention: rosuvastatin 40 mg
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg/ER niacin 2 g
Number of subjects: 270

Group type: COMPARATOR
Intervention: ER niacin 2 g
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: rosuvastatin 40 mg/ER niacin 1 g
Number of subjects: 270

Group type: COMPARATOR
Intervention: rosuvastatin alone
Number of subjects: 270
Study: 10650230

Group type: EXPERIMENTAL
Intervention: Diclofenac ophthalmic solution
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control vehicle drops
Number of subjects: 49